Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-22-048135)

Filing Details

Accession Number:: 0001209191-22-048135
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2022-08-31 16:32:16
Reporting Period:: 2022-08-29

Accepted Time:: 2022-08-31 16:32:16
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1841330	Pasithea Therapeutics Corp.	KTTA	()	DE

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1516478	Camac Fund, Lp	Camac Capital, Llc 350 Park Avenue, 13Th Floor New York NY 10022		No	No	No	Yes
1790877	Eric Shahinian	C/O Camac Partners Llc 350 Park Avenue, 13Th Floor New York NY 10022		No	No	No	Yes
1867496	Camac Partners, Llc	350 Park Avenue, 13Th Floor New York NY 10022		No	No	No	Yes
1867498	Camac Capital, Llc	350 Park Avenue, 13Th Floor New York NY 10022		No	No	No	Yes

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2022-08-29	5,000	$1.17	1,617,329	No	4	P	Indirect	See footnote
Common Stock	Acquisiton	2022-08-30	17,828	$1.15	1,635,157	No	4	P	Indirect	See footnote

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	See footnote
No	4	P	Indirect	See footnote

Footnotes

The number of shares beneficially owned includes 1,000 shares inadvertently omitted from the Reporting Persons' Form 3 filed 08/15/2022.
The shares are held by Camac Fund, LP. ("Camac Fund"). Eric Shahinian is the managing member of Camac Capital, LLC, which is the general partner of Camac Fund and the managing member of Camac Partners, LLC.